Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-THEIA: Adalimumab and Methotrexate in Non-infectious Uveitis
NCT04798755Phase 3Unknown
- Sponsor
- Hospital Clínico San Carlos
- Start
- Jan 2022
- Primary completion
- Oct 2024
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab, methotrexate in noninfectious uveitis (NIU), sponsored by Hospital Clínico San Carlos. Status: unknown.
02
Drugs
adalimumabmethotrexate
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT04798755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04798755.